Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Biochimica Et Biophysica Acta|April 13, 1981
Light-harvesting systems of brown algae and diatoms. Isolation and characterization of chlorophyll a/c and chlorophyll a/fucoxanthin pigment-protein complexesR S Alberte, A L Friedman, D L Gustafson, et al.Molecular Pharmacology|October 1, 1996
Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinonesD L Gustafson, H D Beall, E M Bolton, et al.Veterinary and Comparative Oncology|May 17, 2011
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograftJ L Sottnik, R J Hansen, D L Gustafson, et al.Veterinary and Comparative Oncology|May 21, 2016
The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicineJ S Fowles, D D Dailey, D L Gustafson, et al.Mutation Research|November 4, 1996
A low, adaptive dose of gamma-rays reduced the number and altered the spectrum of S1- mutants in human-hamster hybrid AL cellsA M Ueno, D B Vannais, D L Gustafson, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 4, 2000
Comparative hepatocarcinogenicity of hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, and 1,4-dichlorobenzene: application of a medium-term liver focus bioassay and molecular and cellular indicesD L Gustafson, M E Long, R S Thomas, et al.Journal of Veterinary Pharmacology and Therapeutics|December 16, 2015
Limited sampling pharmacokinetics of subcutaneous ondansetron in healthy geriatric cats, cats with chronic kidney disease, and cats with liver diseaseR L Fitzpatrick, L A Wittenburg, R J Hansen, et al.Journal of Veterinary Pharmacology and Therapeutics|December 17, 2013
Oral, subcutaneous, and intravenous pharmacokinetics of ondansetron in healthy catsJ M Quimby, R C Lake, R J Hansen, et al.Mutagenesis|May 3, 2000
Vanillin (3-methoxy-4-hydroxybenzaldehyde) inhibits mutation induced by hydrogen peroxide, N-methyl-N-nitrosoguanidine and mitomycin C but not (137)Cs gamma-radiation at the CD59 locus in human-hamster hybrid A(L) cellsD L Gustafson, H R Franz, A M Ueno, et al.Toxicology and Applied Pharmacology|July 18, 2000
A physiologically based pharmacodynamic analysis of hepatic foci within a medium-term liver bioassay using pentachlorobenzene as a promoter and diethylnitrosamine as an initiatorR S Thomas, R B Conolly, D L Gustafson, et al.Pageof 5